113 related articles for article (PubMed ID: 25960387)
21. Comparison of immunohistochemistry, DNA sequencing and allele-specific PCR for the detection of IDH1 mutations in gliomas.
Loussouarn D; Le Loupp AG; Frenel JS; Leclair F; Von Deimling A; Aumont M; Martin S; Campone M; Denis MG
Int J Oncol; 2012 Jun; 40(6):2058-62. PubMed ID: 22447191
[TBL] [Abstract][Full Text] [Related]
22. Advances in Brain Cancer: Creating Monoallelic Single Point Mutation in IDH1 by Single Base Editing.
Shah SR; Quinones-Hinojosa A; Xia S
J Oncol Res Ther; 2019; 5(5):. PubMed ID: 31328182
[TBL] [Abstract][Full Text] [Related]
23. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
24. Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers.
Kang MR; Kim MS; Oh JE; Kim YR; Song SY; Seo SI; Lee JY; Yoo NJ; Lee SH
Int J Cancer; 2009 Jul; 125(2):353-5. PubMed ID: 19378339
[TBL] [Abstract][Full Text] [Related]
25. Establishment of a novel monoclonal antibody SMab-1 specific for IDH1-R132S mutation.
Kaneko MK; Tian W; Takano S; Suzuki H; Sawa Y; Hozumi Y; Goto K; Yamazaki K; Kitanaka C; Kato Y
Biochem Biophys Res Commun; 2011 Mar; 406(4):608-13. PubMed ID: 21352804
[TBL] [Abstract][Full Text] [Related]
26. The development of a hiPSC-based platform to identify tissue-dependencies of IDH1 R132H.
Mehjardi NZ; Kessler J; Sanin AY; Picard D; Westhoff P; Nickel AC; Uhlmann C; Shi W; Steiger HJ; Remke M; Fischer I; Vordermark D; Croner RS; Kahlert UD
Cell Death Discov; 2023 Dec; 9(1):452. PubMed ID: 38086797
[TBL] [Abstract][Full Text] [Related]
27. Altered Metabolism of Leukemic Cells: New Therapeutic Opportunity.
Starkova J; Hermanova I; Hlozkova K; Hararova A; Trka J
Int Rev Cell Mol Biol; 2018; 336():93-147. PubMed ID: 29413894
[TBL] [Abstract][Full Text] [Related]
28. Oncogenic R132 IDH1 Mutations Limit NADPH for De Novo Lipogenesis through (D)2-Hydroxyglutarate Production in Fibrosarcoma Cells.
Badur MG; Muthusamy T; Parker SJ; Ma S; McBrayer SK; Cordes T; Magana JH; Guan KL; Metallo CM
Cell Rep; 2018 Nov; 25(6):1680. PubMed ID: 30404018
[No Abstract] [Full Text] [Related]
29. Alzheimer-Related Protein Suppresses Gliomas.
Cancer Discov; 2020 Mar; 10(3):332. PubMed ID: 32046983
[TBL] [Abstract][Full Text] [Related]
30. [Relations between metabolism of lipoids and the development of tumors; review].
D'ANCONA S
Riv Anat Patol Oncol; 1955 Dec; 10(6):883-8. PubMed ID: 13351301
[No Abstract] [Full Text] [Related]
31. Study Suggests Treatment Approaches for Cholangiocarcinomas.
Cancer Discov; 2017 Jun; 7(6):OF6. PubMed ID: 28424193
[TBL] [Abstract][Full Text] [Related]
32. A new role for IDH1 in the control of ovarian cancer cells metabolism and senescence.
Sonego M; Baldassarre G
Ann Transl Med; 2020 Jun; 8(12):780. PubMed ID: 32647705
[No Abstract] [Full Text] [Related]
33. Lipid metabolism.
Young IS; Nicholls PD
Curr Opin Lipidol; 1994 Aug; 5(4):U95-9. PubMed ID: 7981952
[No Abstract] [Full Text] [Related]
34. Lipid metabolism.
de Bruin TW
Curr Opin Lipidol; 1994 Oct; 5(5):U117-23. PubMed ID: 7858900
[No Abstract] [Full Text] [Related]
35. Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype.
Cuyàs E; Fernández-Arroyo S; Corominas-Faja B; Rodríguez-Gallego E; Bosch-Barrera J; Martin-Castillo B; De Llorens R; Joven J; Menendez JA
Oncotarget; 2015 May; 6(14):12279-96. PubMed ID: 25980580
[TBL] [Abstract][Full Text] [Related]
36. Mutant IDH1: An immunotherapeutic target in tumors.
Schumacher T; Bunse L; Wick W; Platten M
Oncoimmunology; 2014 Dec; 3(12):e974392. PubMed ID: 25964867
[TBL] [Abstract][Full Text] [Related]
37. IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism.
Izquierdo-Garcia JL; Viswanath P; Eriksson P; Cai L; Radoul M; Chaumeil MM; Blough M; Luchman HA; Weiss S; Cairncross JG; Phillips JJ; Pieper RO; Ronen SM
Cancer Res; 2015 Aug; 75(15):2999-3009. PubMed ID: 26045167
[TBL] [Abstract][Full Text] [Related]
38. IDH mutations in cancer and progress toward development of targeted therapeutics.
Dang L; Yen K; Attar EC
Ann Oncol; 2016 Apr; 27(4):599-608. PubMed ID: 27005468
[TBL] [Abstract][Full Text] [Related]
39. Enigmas of IDH mutations in hematology/oncology.
Heuser M; Araujo Cruz MM; Goparaju R; Chaturvedi A
Exp Hematol; 2015 Aug; 43(8):685-97. PubMed ID: 26032956
[TBL] [Abstract][Full Text] [Related]
40. Metabolic and mind shifts: from glucose to glutamine and acetate addictions in cancer.
Corbet C; Feron O
Curr Opin Clin Nutr Metab Care; 2015 Jul; 18(4):346-53. PubMed ID: 26001655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
